Acne Vulgaris
Conditions
Keywords
AcneVulgaris, Vitamin D
Brief summary
The goal of this clinical trial is to compare in acne vulgaris patients. The main question it aims to answer is: • To assess the therapeutic benefit of vitamin D supplement in acne vulgaris treatment, following a 2-month treatment regimen that includes vitamin D supplementation compared to conventional (systemic azithromycin and topical retinoid) treatment alone. Participants will receive vitamin D supplements in addition to capsule Azithromycin and topical retinoid. Researchers will compare groups to determine efficacy of Vitamin D supplements in the treatment of Acne vulgaris.
Interventions
DIETARY_SUPPLEMENTD Max Drops
Vitamin D
DRUGAzithromycin 250 milligram Oral Capsule
Anti Biotic
DRUGAdapalene
Retinoid
Sponsors
HITEC-Institute of Medical Sciences
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
13 Years to 40 Years
Healthy volunteers
Yes
Inclusion criteria
* Individuals aged between 13 and 40 years with diagnoses of Acne vulgaris are included.
Exclusion criteria
* Individuals currently undergoing treatment for polycystic ovary syndrome (PCOs) * Those with obesity * Individuals employing vitamin supplementation * Those under the influence of topical or systemic steroids and acne treatment in the last 2 months.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Efficacious | 2 months | Improvement in Global Acne Grading System Score from baseline to after 2 months of treatment |
Countries
Pakistan
Contacts
Primary ContactAqsa Naheed, MBBS
Outcome results
None listed